BRIDGEWATER, N.J., Sept. 19 /PRNewswire-FirstCall/ -- Dermik Laboratories, the dermatology business of sanofi-aventis U.S. LLC, announced today the Food and Drug Administration (FDA) has accepted for filing the company's supplemental premarket approval application (s-PMA) for Sculptra® (injectable poly-L-lactic acid) for facial cosmetic use.
